Φορτώνει......
Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck
Cetuximab is a monoclonal antibody able to inhibit and to degrade the transmembrane receptor Her-1, also known as epidermal growth factor receptor (EGFR). The inhibition of EGFR is of major importance since the receptor influences many important tumor cell activities including tumor growth, neo-angi...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | , |
---|---|
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
Dove Medical Press
2007
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2376084/ https://ncbi.nlm.nih.gov/pubmed/18473010 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|